Association of the μ-opioid receptor gene with type 2 diabetes mellitus in an African American population-Reference-Cited by-同舟云学术

Association of the μ-opioid receptor gene with type 2 diabetes mellitus in an African American population

Published:2006-01 Issue:1 Volume:87 Page:54-60
ISSN:1096-7192
Container-title:Molecular Genetics and Metabolism
language:en
Short-container-title:Molecular Genetics and Metabolism

Author:

Gallagher Carla J.,Gordon Candace J.,Langefeld Carl D.,Mychaleckyj Josyf C.,Freedman Barry I.,Rich Stephen S.,Bowden Donald W.,Sale Michèle M.

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference31 articles.

1. Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study;Brancati;JAMA,2000

2. National Diabetes Information Clearinghouse (2002). “National Diabetes Statistics,” National Institutes of Diabetes and Digestive Kidney Diseases, Bethesda, MD.

3. A genome-wide scan for type 2 diabetes in African-American families reveals evidence for a locus on chromosome 6q;Sale;Diabetes,2004

4. Autoradiographic localization of beta-endorphin binding in the pancreas;Zhang;Mol. Cell. Neurosci.,1994

5. Rapid induction of insulin resistance in opioid mu-receptor knock-out mice;Cheng;Neurosci. Lett.,2003

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining samidorphan with olanzapine to mitigate weight gain as a side effect in schizophrenia treatment;Postępy Psychiatrii i Neurologii;2023

2. In vivo Characterization of the Opioid Receptor–Binding Profiles of Samidorphan and Naltrexone in Rats: Comparisons at Clinically Relevant Concentrations;Neuropsychiatric Disease and Treatment;2022-11

3. Hepatic transcript signatures predict atherosclerotic lesion burden prior to a 2-year high cholesterol, high fat diet challenge;PLOS ONE;2022-08-04

4. Opioid antagonism mitigates antipsychotic-associated weight gain: focus on olanzapine;CNS Spectrums;2022-03-03

5. An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder;Neuropsychiatric Disease and Treatment;2021-09